shopping cart Your cart is empty
  • Home
  • Chemical and Material
  • Antiseptics And Disinfectants Market By Application (Food & Life Science, Medical Devices, Pharmaceuticals), By Equipment’s & Ser...

Antiseptics And Disinfectants Market By Application (Food & Life Science, Medical Devices, Pharmaceuticals), By Equipment’s & Services (Filteration, Heat, Low Tempreture), By Disinfectants (Disinfectant Wipes, Disinfectants, Disinfectors, Endoscope Reprocessing, Medical Non-Woven), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: May 30, 2016

Key Findings


The global antiseptics and disinfectants market is expected to grow at the CAGR of 11.5% during 2015-2022. The major factor which is contributing towards the growth of this market is the increasing prevalence of infectious diseases. The increasing prevalence of infectious diseases and outbreaks of swine flues are significantly contributing in the growth of antiseptics and disinfectants market. The increasing number of surgeries is also impacting the growth of the global market. The increasing aging population is having a huge impact on the growth of global antiseptics and disinfectants market. According to WHO, the world aged population in 2015 was 900 million and by the end of 2050 is expected to reach 2 billion. By the end of 2050, geriatric population of China is expected to reach around 125 million ageing 80 years or more, and around 434 million people across the globe. Approximately 80% people are expected to be living in low and middle income countries by the end of 2050. As the increasing aging population is one of the major driving factors of global antiseptics and disinfectants market. The increasing prevalence of chronic diseases such as cancer, kidney failure cardiovascular disorders, etc. is increasing, expected to create huge opportunities in the forecast period. The rising awareness of food quality is also creating the opportunities for the antiseptics and disinfectants market. According to national cancer institute in 2016, around 1.6 million cases of cancer were diagnosed in the United States alone and 595,690 people die from cancer disease. However, strict government regulations to control the functioning of various pharma companies are the major restraint available in the global antiseptics and disinfectants market. Although there are many factors which are driving growth of the market, however there are some challenges such as use of chemical compound in the manufacture of antiseptics and disinfectants, which can be overcomed in the forecast period.


Market Segment Insight


The market is majorly segmented on the basis of equipment & services, applications and disinfectants and geography. On the basis of applications, the global market of antiseptics and disinfectants is segmented into food & life sciences, medical devices, pharmaceuticals. Equipment & services segment is divided into filtration, heat, low temperature, sterilization. The disinfectants segment is further divided into disinfectant wipes, disinfectants, and disinfectors, endoscope reprocessing and medical non-woven. The end-user industry segment is contributing a large share in the growth of global antiseptics and disinfectants market. The disinfectors segment is further segmented into flusher disinfectors, washer disinfectors. The medical non-woven market is sub divided into drapes, facemasks, gowns, sterilization wraps.


Regional Insight


Globally, the antiseptics and disinfectants market is segmented into North America, Europe, APAC and ROW. The North America dominates the global market followed by Europe, APAC and ROW; the North American market is experiencing robust growth due to increasing prevalence of chronic diseases in the region. According to national cancer institute around 1.6 million new cases of cancer are found in United States. Approx. 454.8 people on 100,000 men and women diagnosed cancer in US. In 2014 around 15780 adolescents and children were treated for cancer among which 1960 died. The Asia Pacific market is growing with a high CAGR, the growth in this region is due to the increasing medical tourism in the countries of this region, and the increasing aging population of emerging countries. According to WHO, China is expected to have 125 million people aged above 80 by the end of 2050. Thus there is an increasing demand for low cost medical treatment in emerging countries such as India, China and Thailand, which is creating huge opportunity in the global antiseptic and disinfectant market. The rising concern for the quality food in Asia Pacific countries is also creating huge opportunities for growth in the global market. The Asian market is majorly driven by the increasing aging population and the factor which is negatively affecting the growth is the strict government regulations.


Competitive Insights


Some of the key market players are 3M Co., American Biotech Labs LLC, Cardinal Health Inc., Colgate-Palmolive Co., Dow Microbial Control, DuPont Medical Chemical Corp., Johnson & Johnson Services Inc., Procter & Gamble Co., and Metrex Research Corp.etc. Acquisitions, mergers, collaborations, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market. On 11 Dec. 2015, DuPont and Dow Chemical merged together, with the focus to reshape the agriculture industry, which is also driving the growth in the American Industry. October 4, 2015, Cardinal Health acquired the Johnson & Johnson’s Cordis business for 1.944 billion. The acquisition of Cordis helped to reinforce portfolio of Cardinal Health which generally deals in physician preferences products such as cardiovascular, orthopedics areas and wound management. In 2014 Cordis had the annual turnover of around $780 million which is divided equally in cardiology and endovascular products.

CHAP 1. METHODOLOGY & SCOPE 11
1.1. RESEARCH METHODOLOGY 11
1.2. RESEARCH SCOPE & ASSUMPTIONS 11
1.3. LIST OF DATA SOURCES 11


CHAP 2. EXECUTIVE SUMMARY 12
2.1. GLOBAL ANTISEPTICS AND DISINFECTANTS SUMMARY & KEY BUYING CRITERIA 12
2.2. GLOBAL ANTISEPTICS AND DISINFECTANTS OUTLOOK 12
2.3. MARKET SEGMENTATION ANALYSIS 12
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 12
2.5. GLOBAL ANTISEPTICS AND DISINFECTANTS VALUE CHAIN ANALYSIS 12
2.6. VENDOR LANDSCAPE 12


CHAP 3. GLOBAL ANTISEPTICS AND DISINFECTANTS 13
3.1. MARKET DRIVER ANALYSIS 13
3.2. MARKET RESTRAINT ANALYSIS 13
3.3. KEY OPPORTUNITIES 13
3.4. CHALLENGES 13


CHAP 4. INDUSTRY ANALYSIS 14
4.1. GLOBAL ANTISEPTICS AND DISINFECTANTS – PORTER’S FIVE FORCE MODEL 14
4.2. GLOBAL ANTISEPTICS AND DISINFECTANTS – PESTEL ANALYSIS 14
4.3. GLOBAL ANTISEPTICS AND DISINFECTANTS – GAP ANALYSIS 14


CHAP 5. GLOBAL ANTISEPTICS AND DISINFECTANTS BY APPLICATION 2012-2022 ($ MILLION) 15
5.1. GLOBAL FOOD & LIFE SCIENCE MARKET 2012-2022 ($ MILLION) 15
5.2. GLOBAL MEDICAL DEVICES MARKET 2012-2022 ($ MILLION) 15
5.3. GLOBAL PHARMACEUTICALS MARKET 2012-2022 ($ MILLION) 15


CHAP 6. GLOBAL ANTISEPTICS AND DISINFECTANTS BY EQUIPMENT’S & SERVICES 2012-2022 ($ MILLION) 16
6.1. GLOBAL FILTERATION MARKET 2012-2022 ($ MILLION) 16
6.2. GLOBAL HEAT MARKET 2012-2022 ($ MILLION) 16
6.3. GLOBAL LOW TEMPRETURE MARKET 2012-2022 ($ MILLION) 16


CHAP 7. GLOBAL ANTISEPTICS AND DISINFECTANTS BY DISINFECTANTS 2012-2022 ($ MILLION) 17
7.1. GLOBAL DISINFECTANT WIPES MARKET 2012-2022 ($ MILLION) 17
7.2. GLOBAL DISINFECTANTS MARKET 2012-2022 ($ MILLION) 17
7.3. GLOBAL DISINFECTORS MARKET 2012-2022 ($ MILLION) 17
7.3.1. GLOBAL FLUSHER DISINFECTORS MARKET 2012-2022 ($ MILLION) 17
7.3.2. GLOBAL WASHER DISINFECTORS MARKET 2012-2022 ($ MILLION) 17
7.4. GLOBAL ENDOSCOPE REPROCESSING MARKET 2012-2022 ($ MILLION) 17
7.5. GLOBAL MEDICAL NON-WOVEN MARKET 2012-2022 ($ MILLION) 17
7.5.1. GLOBAL DRAPES MARKET 2012-2022 ($ MILLION) 17
7.5.2. GLOBAL FACEMARKS MARKET 2012-2022 ($ MILLION) 17
7.5.3. GLOBAL GOWNS MARKET 2012-2022 ($ MILLION) 17
7.5.4. GLOBAL STERILIZATION WRAPS MARKET 2012-2022 ($ MILLION) 17


CHAP 8. GLOBAL ANTISEPTICS AND DISINFECTANTS , REGIONAL OUTLOOK 2012-2022 ($ MILLION) 18
8.1. GLOBAL ANTISEPTICS AND DISINFECTANTS BY REGION 2012-2022 ($ MILLION) 18
8.2. NORTH AMERICA 18
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 18
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
8.2.3.1. U.S. 18
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
8.2.3.2. CANADA 18
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
8.3. EUROPE 18
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 18
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
8.3.3.1. GERMANY 18
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.3.3.2. UK 19
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.3.3.3. FRANCE 19
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.3.3.4. RUSSIA 19
8.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
8.3.3.4.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
8.3.3.5. REST OF EUROPE 19
8.3.3.5.1. ROE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 20
8.3.3.5.2. ROE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 20
8.4. ASIA PACIFIC 20
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.4.3.1. CHINA 20
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.4.3.2. INDIA 20
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
8.4.3.3. JAPAN 20
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 20
8.4.3.4. ROAPAC 20
8.4.3.4.1. ROAPAC MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 21
8.4.3.4.2. ROAPAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 21
8.5. REST OF THE WORLD 21
8.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
8.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.5.3.1. LATIN AMERICA 21
8.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
8.5.3.2. MIDDLE EAST AND AFRICA 21
8.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
8.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21


CHAP 9. COMPETITIVE LANDSCAPE 22
9.1. 3M CO. 23
9.1.1. COMPANY OVERVIEW 23
9.1.2. SCOT ANALYSIS 23
9.1.3. PRODUCT BENCHMARKING 23
9.1.4. STRATEGIC INITIATIVES 23
9.2. ABC COMPOUNDING CO. INC. 23
9.2.1. COMPANY OVERVIEW 23
9.2.2. SCOT ANALYSIS 23
9.2.3. PRODUCT BENCHMARKING 23
9.2.4. STRATEGIC INITIATIVES 23
9.3. AMERICAN BIOTECH LABS LLC 23
9.3.1. COMPANY OVERVIEW 23
9.3.2. SCOT ANALYSIS 23
9.3.3. PRODUCT BENCHMARKING 23
9.3.4. STRATEGIC INITIATIVES 23
9.4. BIO-CIDE INTERNATIONAL INC. 23
9.4.1. COMPANY OVERVIEW 23
9.4.2. SCOT ANALYSIS 23
9.4.3. PRODUCT BENCHMARKING 23
9.4.4. STRATEGIC INITIATIVES 23
9.5. CARDINAL HEALTH INC. 23
9.5.1. COMPANY OVERVIEW 23
9.5.2. SCOT ANALYSIS 23
9.5.3. PRODUCT BENCHMARKING 23
9.5.4. STRATEGIC INITIATIVES 23
9.6. COLGATE-PALMOLIVE CO. 23
9.6.1. COMPANY OVERVIEW 23
9.6.2. SCOT ANALYSIS 24
9.6.3. PRODUCT BENCHMARKING 24
9.6.4. STRATEGIC INITIATIVES 24
9.7. DOW MICROBIAL CONTROL 24
9.7.1. COMPANY OVERVIEW 24
9.7.2. SCOT ANALYSIS 24
9.7.3. PRODUCT BENCHMARKING 24
9.7.4. STRATEGIC INITIATIVES 24
9.8. DUPONT MEDICAL CHEMICAL CORP. 24
9.8.1. COMPANY OVERVIEW 24
9.8.2. SCOT ANALYSIS 24
9.8.3. PRODUCT BENCHMARKING 24
9.8.4. STRATEGIC INITIATIVES 24
9.9. JOHNSON & JOHNSON SERVICES INC. 24
9.9.1. COMPANY OVERVIEW 24
9.9.2. SCOT ANALYSIS 24
9.9.3. PRODUCT BENCHMARKING 24
9.9.4. STRATEGIC INITIATIVES 24
9.10. MELROSE CHEMICAL LTD. 24
9.10.1. COMPANY OVERVIEW 24
9.10.2. SCOT ANALYSIS 24
9.10.3. PRODUCT BENCHMARKING 24
9.10.4. STRATEGIC INITIATIVES 24
9.11. METREX RESEARCH CORP. 24
9.11.1. COMPANY OVERVIEW 24
9.11.2. SCOT ANALYSIS 24
9.11.3. PRODUCT BENCHMARKING 24
9.11.4. STRATEGIC INITIATIVES 24
9.12. NUVA PHARMACEUTICALS INC. 25
9.12.1. COMPANY OVERVIEW 25
9.12.2. SCOT ANALYSIS 25
9.12.3. PRODUCT BENCHMARKING 25
9.12.4. STRATEGIC INITIATIVES 25
9.13. PROCTER & GAMBLE CO. 25
9.13.1. COMPANY OVERVIEW 25
9.13.2. SCOT ANALYSIS 25
9.13.3. PRODUCT BENCHMARKING 25
9.13.4. STRATEGIC INITIATIVES 25
9.14. STERIS CORP. 25
9.14.1. COMPANY OVERVIEW 25
9.14.2. SCOT ANALYSIS 25
9.14.3. PRODUCT BENCHMARKING 25
9.14.4. STRATEGIC INITIATIVES 25
9.15. THE CLOROX CO. 25
9.15.1. COMPANY OVERVIEW 25
9.15.2. SCOT ANALYSIS 25
9.15.3. PRODUCT BENCHMARKING 25
9.15.4. STRATEGIC INITIATIVES 25

TABLE 1 GLOBAL ANTISEPTICS AND DISINFECTANTS BY APPLICATION 2012-2022 ($ MILLION) 25
TABLE 2 GLOBAL FOOD & LIFE SCIENCE MARKET 2012-2022 ($ MILLION) 25
TABLE 3 GLOBAL MEDICAL DEVICES MARKET 2012-2022 ($ MILLION) 25
TABLE 4 GLOBAL PHARMACEUTICALS MARKET 2012-2022 ($ MILLION) 26
TABLE 5 GLOBAL ANTISEPTICS AND DISINFECTANTS BY EQUIPMENT’S & SERVICES 2012-2022 ($ MILLION) 26
TABLE 6 GLOBAL FILTERATION MARKET 2012-2022 ($ MILLION) 26
TABLE 7 GLOBAL HEAT MARKET 2012-2022 ($ MILLION) 26
TABLE 8 GLOBAL LOW TEMPRETURE MARKET 2012-2022 ($ MILLION) 26
TABLE 9 GLOBAL STERILIZATION MARKET 2012-2022 ($ MILLION) 26
TABLE 10 GLOBAL ANTISEPTICS AND DISINFECTANTS BY DISINFECTANTS 2012-2022 ($ MILLION) 26
TABLE 11 GLOBAL DISINFECTANT WIPES MARKET 2012-2022 ($ MILLION) 26
TABLE 12 GLOBAL DISINFECTANTS MARKET 2012-2022 ($ MILLION) 26
TABLE 13 GLOBAL DISINFECTORS MARKET 2012-2022 ($ MILLION) 26
TABLE 14 GLOBAL FLUSHER DISINFECTORS MARKET 2012-2022 ($ MILLION) 26
TABLE 15 GLOBAL WASHER DISINFECTORS MARKET 2012-2022 ($ MILLION) 26
TABLE 16 GLOBAL ENDOSCOPE REPROCESSING MARKET 2012-2022 ($ MILLION) 26
TABLE 17 GLOBAL MEDICAL NON-WOVEN MARKET 2012-2022 ($ MILLION) 26
TABLE 18 GLOBAL DRAPES MARKET 2012-2022 ($ MILLION) 26
TABLE 19 GLOBAL FACEMARKS MARKET 2012-2022 ($ MILLION) 26
TABLE 20 GLOBAL GOWNS MARKET 2012-2022 ($ MILLION) 26
TABLE 21 GLOBAL STERILIZATION WRAPS MARKET 2012-2022 ($ MILLION) 26
TABLE 22 NORTH AMERICA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 26
TABLE 23 NORTH AMERICA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 26
TABLE 24 NORTH AMERICA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
TABLE 25 U.S. GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 27
TABLE 26 U.S. GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
TABLE 27 CANADA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 27
TABLE 28 CANADA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 –2022 ($ MILLION) 27
TABLE 29 CANADA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
TABLE 30 EUROPE GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 27
TABLE 31 EUROPE GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 27
TABLE 32 EUROPE GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
TABLE 33 GERMANY GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST, 2012 – 2022 ($ MILLION) 27
TABLE 34 GERMANY METABOLOMICS TECHNOLOGY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
TABLE 35 UK GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 27
TABLE 36 UK GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
TABLE 37 ASIA PACIFIC GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 27
TABLE 38 ASIA PACIFIC GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 27
TABLE 39 ASIA PACIFIC GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 27
TABLE 40 CHINA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 27
TABLE 41 CHINA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 28
TABLE 42 INDIA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 28
TABLE 43 INDIA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 28
TABLE 44 JAPAN GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 28
TABLE 45 JAPAN GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 28
TABLE 46 MIDDLE EAST & AFRICA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 28
TABLE 47 MIDDLE EAST & AFRICA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 28
TABLE 48 LATIN AMERICA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 28
TABLE 49 LATIN AMERICA GLOBAL ANTISEPTICS AND DISINFECTANTS ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 28

FIGURE 1 MARKET SHARE BY REGIONS 28
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)